TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 72 filers reported holding TRINITY BIOTECH PLC in Q4 2016. The put-call ratio across all filers is 55.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $753,000 | -66.0% | 108,812 | -32.5% | 1.71% | -69.2% |
| Q3 2016 | $2,215,000 | +21.1% | 161,284 | 0.0% | 5.56% | +29.6% |
| Q2 2016 | $1,829,000 | -2.8% | 161,284 | 0.0% | 4.29% | -0.8% |
| Q1 2016 | $1,881,000 | -7.8% | 161,284 | -7.0% | 4.33% | -40.9% |
| Q4 2015 | $2,040,000 | – | 173,427 | – | 7.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |